TEXT

Top Abstract Text References

There are six subspecies of Salmonella enterica that are capable of colonizing both warm- and cold-blooded animals (1, 9). S. enterica subspecies I serovars are strictly associated with infection of warm-blooded animals and can cause a wide a range of diseases, including gastroenteritis, bacteremia, and typhoid fever (11). S. enterica serovar Typhimurium (from here on referred to as serovar Typhimurium) is the causative agent of gastroenteritis in humans and a typhoid-like disease in mice (11). Serovar Typhimurium survives and replicates within phagocytic cells of the reticuloendothelial system, resulting in the release of proinflammatory cytokines in response to bacterial compounds such as lipopolysaccharide (LPS) and peptidoglycan (11, 16, 17, 20). Two of these inflammatory cytokines, tumor necrosis factor alpha (TNF-) and gamma interferon (IFN-), are required for host clearance of Salmonella infections (11, 12, 16, 18). Treatment of infected animals with IFN- decreases the numbers of bacteria found in the spleen early in infection, and injection of anti-TNF- or anti-IFN- abolishes the ability of mice to clear sublethal doses of serovar Typhimurium (12, 26, 27). Recently, it has been reported that modified Salmonella lipid A (an LPS component) can reduce the LPS-mediated expression of TNF- by human monocytes and E-selectin by endothelial cells (14). These lipid A modifications are regulated by the PhoP/PhoQ virulence regulon (7, 13), suggesting a potential role for PhoP/PhoQ-activated genes not only in intracellular survival but also in lowering cytokine and chemokine production.

In the present study we characterized the virulence properties and evolutionary history of a host-induced serovar Typhimurium factor with potential immunomodulatory functions. A previous study described a PhoP/PhoQ-dependent, macrophage-inducible promoter, fmi-14, which exhibited a 22-fold induction within murine macrophages (36). To identify the open reading frame (ORF) associated with fmi-14, we isolated an adjacent 2.2-kb serovar Typhimurium DNA fragment by recombinational cloning (6). Sequence analysis of this fragment revealed a single ORF (mig-14) encoding a putative 298-amino-acid (aa) soluble polypeptide with limited homology to Bacillus subtilis RecG, an ATP-dependent DNA helicase (27% identity over a 102-aa overlap), and the LysR-like activator AppY from Escherichia coli (30% identity over 59 aa). To disrupt mig-14, a 1.6-kb ClaI fragment containing the 5' end of mig-14 was cloned into the allelic-exchange vector pRTP-1 (34), and an Kan^r (aph) cassette (8) was inserted at a unique BclI site within the mig-14 coding sequence. The resulting plasmid was transformed into serovar Typhimurium strain SL1343R (trp rpsL) and gene replacement events were identified by Southern blot hybridization. The mig-14::aph mutation was mobilized into the virulent strain SL1344 (xyl hisG rpsL) by P22-HT-mediated transduction to create the strain RVY-5.

Virulence defects of mig-14 mutants. We characterized the virulence defects of RVY-5 by determining the competitive index (CI) of the mutant strains at various time points. The CI is the ratio of RVY-5 to SL1344 present in different organs after challenge with a 1:1 ratio of wild-type to mutant bacteria. Groups of four female BALB/c mice were injected intraperitoneally with an equal mixture of SL1344 and RVY-5 (5 × 10² bacteria total). The mice were killed at days 3 and 5 postinfection; the spleens and livers were collected, homogenized, and plated on selective media to determine the number of CFU of each input strain. At day 3, RVY-5 and SL1344 were equally efficient at colonizing the liver (mean CI = 0.49 ± 0.29) and spleen (mean CI = 0.81 ± 0.27). However, by day 5, RVY-5 showed an ~10- to 50-fold reduction in its ability to compete with SL1344 (liver mean CI = 0.09 ± 0.07; spleen mean CI = 0.17 ± 0.16). To determine whether the mig-14 mutation would impair the ability of serovar Typhimurium to colonize the gut-associated lymphoid tissue, we performed mixed infections and calculated the CI of RVY-5 after oral inoculation (Fig. 1A). Groups of four mice were inoculated intragastrically with equal numbers (10⁶ bacteria total) of SL1344 and RVY-5. The animals were killed at days 3 and 5 postinfection, and bacteria from the Peyer's patches (PP), mesenteric lymph nodes (MLN), spleen, and liver were recovered on selective plates. At day 3 postinfection, RVY-5 colonized the PP as efficiently as SL1344 (at this time point only two out of the four mice showed bacterial spread beyond the MLN). At day 5, the bacterial load of RVY-5 in the PP was still similar to that of SL1344, yet we observed a 15- to 30-fold decrease in RVY-5's CI in the spleen and liver (Fig. 1A). Since it is possible that the RVY-5 CI in the spleen and liver reflects a delayed kinetics in the seeding of these organs rather than survival defects, we compared the growth kinetics of RVY-5 in the spleen and liver. Mice were infected orally with either 5 × 10⁶ SL1344 organisms or 5 × 10⁶ RVY-5 organisms (four mice per strain per time point). Animals were killed at days 2, 5, 7, 11, and 13 postinfection, and the numbers of CFU per gram of tissue were determined. Early during infection (day 2 and day 5) the bacterial load in the liver and spleen increased at similar rates in mice infected with both RVY-5 and SL1344. At day 5 the mean log₁₀ CFU of SL1344 was 4.71 ± 0.53 (n = 4) and that of RVY-5 was 4.39 ± 1.01 (n × 4). After day 5, the number of CFU per gram of tissue began to decrease in RVY-5-infected mice, and by day 13, the animals displayed a low-level chronic infection with no outward symptoms of disease (spleen log₁₀ CFU of 4.71 ± 0.18 [n = 3] at day 7, 4.24 ± 0.16 [n = 3] at day 11, and 3.89 ± 1.29 [n = 3] at day 13). In contrast, SL1344 replicated exponentially until the deaths of the animals occurred, between days 7 and 11 (log₁₀ CFU of 7.06 ± 0.12 [n = 4] at day 7 and 7.28 ± 1.38 [n = 4] at day 11). These experiments indicated that RVY-5 was capable of replicating in mice early during infection but was unable to overcome the host defenses at later stages. The bacterial load in mice infected with RVY-5 continued to decrease, so that 45 days after the oral inoculation with >10⁶ CFU, no bacteria could be recovered from infected tissues (data not shown), suggesting that RVY-5 was cleared from tissues rather than persisting as a chronic infection. The oral 50% lethal dose (LD₅₀) for RVY-5 in BALB/c mice was determined by infection with 10-fold dilutions of either SL1344 or RVY-5 and monitored for 45 days. The oral LD₅₀ (31) for RVY-5 was 1.21 × 10⁸ bacteria per mouse, while the LD₅₀ for SL1344 was less than 1 × 10³ bacteria per mouse, suggesting that the competition experiments had underestimated the virulence defects of mig-14 mutants. One possible explanation for the discrepancy between the CI and the LD₅₀ measurements is that the mig-14 mutation may be partially complemented in trans by coinfection with wild-type serovar Typhimurium. In support of this, we have observed that in mixed infections performed with higher infectious doses, mig-14 mutants replicate at rates similar to those of wild-type bacteria (data not shown).

View larger version (17K): [in this window] [in a new window]   FIG. 1.   Virulence defects of mig-14 mutants. (A) Growth defects of RVY-5 in mixed infections. Groups of four mice were infected orally with a 1:1 mixture of SL1344 (wild type) and RVY-5 (mig-14::aph) (106 CFU per mouse). At days 3 and 5 postinfection, PP (), MLN (), spleens (S) (), and livers (L) () were collected and the number of CFU for each strain was determined. The CI for RVY-5 was calculated as the ratio of RVY-5 to SL1344 recovered from the various organs. At day 3 postinfection, both strains colonized the PP, but RVY-5 was less efficient at colonizing the MLN, S, and L. At day 5, the CI for RVY-5 in the PP was about 1, while the CI in the MLN, L, and S ranged from 0.1 to 0.01 (x = mean CI at day 5). (B) In vivo growth kinetics of RVY-5. Groups of four mice were infected orally with either SL1344 or RVY-5 (5 × 106 organisms per mouse) and the numbers of CFU per gram of spleen were determined at days 2, 5, 7, 11, and 13 (see text). For days 5, 7, and 11 the statistical difference in the mean log10 CFU per gram of spleens infected with either SL1344 or RVY-5 was determined with the Student t test. At day 5, the mean CFU per gram of spleen for SL1344 and RVY-5 were not significantly different (P > 0.2). At day 7 and day 11, the differences in mean CFU per gram of spleen were significant (P < 0.001). Data shown are representative of at least three independent experiments.

Pathology and cytokine profiles of RVY-5-infected mice. We assessed the virulence properties of RVY-5 in tissue culture models of infection and have determined that mig-14 is not required for invasion or replication within cultured or primary macrophages (data not shown). However, RVY-5 has a survival defect in the spleens and livers of infected animals during the later stages of infection, suggesting that RVY-5 may be more susceptible to clearance by the host after the immune system has been stimulated. We investigated the pathology of RVY-5 infections by collecting spleens, livers, MLN, and PP from mice infected with 10⁶ RVY-5 or SL1344 organisms at 2, 6, and 11 days after oral inoculation. The tissues were fixed in 10% buffered neutral formalin solution, processed for routine histology, and examined by light microscopy. In both groups of mice, the most consistent and striking lesions were found in the spleen (Fig. 2) and liver (not shown). At day 2 postinfection, rare to scattered neutrophil accumulations surrounding central necrotic cell debris were found in the splenic red pulp in four out of five mice infected with SL1344 and in three out of five mice infected with RVY-5 (data not shown). However, at day 6, the splenic lesions induced by RVY-5 were strikingly different from lesions induced by SL1344. SL1344-infected mice had severe coalescing splenic necrosis, while RVY-5-infected mice had lower numbers of inflammatory foci composed of mononuclear and fibroblastic cells, few neutrophils, and minimal necrosis (Fig. 2). The severe parenchymal necrosis and the lack of resolution of splenic and liver abscesses in the SL1344-infected mice most likely contributed to the mortality observed after day 6 postinoculation.

View larger version (147K): [in this window] [in a new window]   FIG. 2.   Histopathology of mice infected with SL1344 and RVY-5. At day 6 postinfection, the overall splenic architecture is disrupted in mice infected with SL1344 (A). Necrotic cell debris (white arrow) predominates and rare viable neutrophils (black arrow) are present (C). In contrast, at 6 days postinfection, normal splenic architecture is largely maintained in the spleens of RVY-5-infected mice (B) and the affected areas contain chronic inflammatory cells consisting of mononuclear cells (lymphocytes, macrophages, and plasma cells), fibroblasts, few neutrophils, and minimal necrosis (D). Spleens were removed from infected mice, fixed in 10% buffered neutral formalin, embedded in paraffin, sectioned, and stained with hemotoxylin-eosin. (Bars = 200 µm in panels A and B [×10], and 25 µm in panels C and D [×80].)

View larger version (26K): [in this window] [in a new window]   FIG. 3.   Serum IFN- profiles of infected mice. Blood was collected from the hearts of infected mice on days 2, 5, 7, and 11 after the oral infection, and cytokine enzyme-linked immunosorbent assay for IFN- was performed on the serum. Spleens were removed and homogenized and CFU per gram of spleen were determined. On day 2 all animals displayed serum cytokine levels largely below the threshold of sensitivity of the detection kit. By day 5, mice infected with RVY-5 and SL1344 had similar levels of cytokines and bacterial loads in the spleen (log10 CFU, 3.48 ± 0.9 [n = 4] for SL1344 and 3.31 ± 0.81 [n = 4] for RVY-5). At day 7, RVY-5-infected mice displayed significantly higher levels of IFN- than mice infected with SL1344 even though the bacterial loads present in lymphoid organs were significantly lower (log10 CFU per gram of spleen, 5.75 ± 0.5 [n = 4] for SL1344 and 2.75 ± 0.06 [n = 4] for RVY-5). By day 11, concomitantly with clinical recovery, there was a drastic decrease in cytokine production in mice infected with RVY-5.

mig-14 is part of a horizontally acquired set of genes. The 2.2-kb DNA fragment containing mig-14 has a 39.9% GC content. This is in marked contrast with the GC content of the Salmonella chromosome (52%) (1). Since virulence genes with a low GC content are often part of larger clusters of virulence genes (pathogenicity islands), we isolated a 9-kb EcoRI fragment of the Salmonella chromosome containing mig-14 and adjacent genes. DNA sequence analysis of this region indicated that mig14 maps to centisome 61 (smpB-nrdE intergenic region) in the S. enterica chromosome. This region of the Salmonella chromosome (centisomes 59 to 61) contains several genetic markers that are absent from the E. coli chromosome and which are responsible for some of Salmonella's unique physiological and biochemical characteristics (Fig. 4). The 9-kb EcoRI fragment contained 10 ORFs adjacent to mig-14. One ORF, present at the 5' border of mig-14, encodes a putative protein with significant homology to the Shigella flexneri VirK. VirK is required for the posttranslational processing of the intracellular spreading factor IcsA (28). The nine ORFs at the 3' border of mig-14 encode NxiA, a putative Ni²⁺-containing hydrogenase; TctE and TctD, two previously described regulators of tricarboxylate transport in S. enterica (38); three ORFs encoding a putative periplasmic membrane protein and two integral membrane proteins that are likely responsible for tricarboxylate transport (37); and three ORFs with high nucleotide homology to the E. coli genes o360, ygaF, and gabD (5) (Fig. 4). mig-14 appears to be the only virulence factor gene in this region since serovar Typhimurium strains bearing mutations in virK, nxiA, and the structural (tctI) and regulatory (tctDE) genes of the tct locus were able to kill mice after an oral challenge with 10⁶ bacteria per animal (reference 2 and data not shown). This was not unexpected since we have observed, through the use of gfp fusions, that neither the tct locus nor nxiA is induced in host cells (data not shown).

View larger version (18K): [in this window] [in a new window]   FIG. 4.   The mig-14 locus. (A) mig-14 is located in a region of the Salmonella chromosome known to harbor horizontally acquired virulence genes and other Salmonella-specific genes. The map location of ivi genes, iroN, and virK has been previously described (2, 3, 15, 33). (B) mig-14 is flanked by genes encoding a putative nickel transporter (nxiA) and a tricarboxylate transport apparatus (tctI) and homologues of the S. flexneri virK gene and the E. coli ORFs o360, ygaF, and gabD. In E. coli, o360 and ygaF are adjacent to phage-like ORFs and the tRNA ileY (5). DNA hybridization experiments with PCR-generated probes (black bars) spanning internal regions of virK, mig-14, nxiA, tctDE, and tctC indicated that mig-14 is present only in S. enterica subtypes I, IIIa, and IIIb. In contrast, the adjacent gene nxiA is present in all S. enterica subtypes but not S. bongori, while the tctI locus is found in all Salmonella species tested. The dendrogram (not to scale) shows the evolutionary relationship between varied Salmonella serovars as determined by DNA hybridization and multilocus enzyme electrophoresis (32). Representative serovars tested were S. bongori 48:z35: and 44:r: and S. enterica subgroup I serovars Typhi, Enteriditis, Choleraesuis, Dublin, and Gallinarum, subgroup II serovars Phoenix and 50:b:z6, subgroup IIIa serovars 48:g1z51: and 41:z41z23:, subgroup IIIb serovars 50:k:z and 61::c:z35, and subgroup IV serovars Marina and Chameleon.

Nucleotide sequence accession number. The EcoRI fragment of the Salmonella chromosome containing mig-14 and adjacent genes has been deposited in GenBank under accession no. AF020810.